Safety, feasibility and efficacy of metformin and sitagliptin in patients with a TIA or minor ischaemic stroke and impaired glucose tolerance

Código QR

Safety, feasibility and efficacy of metformin and sitagliptin in patients with a TIA or minor ischaemic stroke and impaired glucose tolerance

Guardado en:

Detalles Bibliográficos
Autores principales:	Diederik W J Dippel, Paul J A M Brouwers, Heleen den Hertog, Elizabeth Osei, Adrienne Zandbergen, Laus J M M Mulder, Peter Koudstaal
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/14749622c8a54c18a4b972eb606367c2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
por: Green J, et al.
Publicado: (2010)

Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
por: Jonathan K Reynolds
Publicado: (2009)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
por: Alexander Sergeevich Ametov, et al.
Publicado: (2010)

Evaluation of microalbuminuria as a prognostic indicator after a TIA or minor stroke in an outpatient setting: the prognostic role of microalbuminuria in TIA evolution (ProMOTE) study
por: William Henley, et al.
Publicado: (2021)

Clinical utility of fixed combinations of sitagliptin&ndash;metformin in treatment of type 2 diabetes
por: Karen Barnard, et al.
Publicado: (2010)

Different levels of blood pressure, different benefit from dual antiplatelet therapy in minor stroke or TIA patients
por: Jie Xu, et al.
Publicado: (2017)

Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled Trial
por: Zhang F, et al.
Publicado: (2021)

Efficacy and safety of evogliptin versus sitagliptin as add on to metformin alone in a combined russian-korean population. Evo-combi trial
por: Alina Y. Babenko, et al.
Publicado: (2018)

The drug interaction potential of berberine hydrochloride when co-administered with simvastatin, fenofibrate, gemfibrozil, metformin, glimepiride, nateglinide, pioglitazone and sitagliptin in beagles
por: Guofei Li, et al.
Publicado: (2022)

Miguel de Cervantes. La tía fingida
por: Jorge García López
Publicado: (2018)

Testemunhos: tia, me dá uma moeda?
por: Maria Luiza Martini
Publicado: (2006)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
por: Shannon A Miller, et al.
Publicado: (2009)

Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA—Analysis From a Nationwide, Multicenter Registry
por: Zefeng Tan, et al.
Publicado: (2021)

The Role of Cardiac MRI in the Management of Ventricular Arrhythmias in Ischaemic and Non-ischaemic Dilated Cardiomyopathy
por: Tom Nelson, et al.
Publicado: (2019)

Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
por: Lei Zhang, et al.
Publicado: (2021)

Corrigendum: Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA—Analysis From a Nationwide, Multicenter Registry
por: Zefeng Tan, et al.
Publicado: (2021)

High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations.
por: Pleun Hombrink, et al.
Publicado: (2011)

El Jardin de tía Violeta: mitología para shilenos
por: Salas, Fabio
Publicado: (2002)

The durability of sitagliptin in elderly patients with type 2 diabetes
por: Hsieh CJ, et al.
Publicado: (2014)

The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes
por: Suvanjaa Sivalingam, et al.
Publicado: (2021)

Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial
por: Teragawa H, et al.
Publicado: (2020)

Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
por: Bo Ahr&eacute;n
Publicado: (2010)

Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
por: Ahren B
Publicado: (2010)

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
por: Omoto S, et al.
Publicado: (2015)

Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial
por: Alam S, et al.
Publicado: (2018)

Precision antiplatelet therapy for the prevention of ischaemic stroke
por: David Wang

Endothelial cells release cardioprotective exosomes that may contribute to ischaemic preconditioning
por: Sean M. Davidson, et al.
Publicado: (2018)

Corrigendum to Feasibility of Utilizing PREMM Score for Lynch Syndrome Identification in an Urban, Minority Patient Population
Publicado: (2021)

Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease
por: Edmund J. Keliher, et al.
Publicado: (2017)

Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus
por: A. V. Simanenkova, et al.
Publicado: (2021)

Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy.
por: Carmel M McVicar, et al.
Publicado: (2010)

Multimodality Imaging to Guide Ventricular Tachycardia Ablation in Patients with Non-ischaemic Cardiomyopathy
por: Ling Kuo, et al.
Publicado: (2020)

Fertilizer effect on proximate composition and nutritive value of exotic/minor vegetable crops
por: Moomin Abu, et al.
Publicado: (2021)

Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes
por: Stolar MW, et al.
Publicado: (2013)

TIA1 oxidation inhibits stress granule assembly and sensitizes cells to stress-induced apoptosis
por: Kyoko Arimoto-Matsuzaki, et al.
Publicado: (2016)

The proteomics analysis of the effects of Zhishi Rhubarb soup on ischaemic stroke
por: Jing-Hua Zhang, et al.
Publicado: (2021)

TIA1 is a gender-specific disease modifier of a mild mouse model of spinal muscular atrophy
por: Matthew D. Howell, et al.
Publicado: (2017)

IDENTITY STRUGGLE OF THE MUSLIM MINORITY AND FIQH AL-AQALLIYAT (FIQH ON MINORITIES)
por: M. Rahmi TELKENAROĞLU
Publicado: (2019)

The pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathies.
por: Reinhold J Medina, et al.
Publicado: (2008)

Editorial: Carmen Lyra y el Centenario de Los cuentos de mi tía Panchita
por: Mariana Lacayo Campos
Publicado: (2020)